From May 26-29, 2022, an international conference will be held on the topic of research into psychedelic substances for the treatment of mental health and substance use disorders, titled From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine. This event is being planned by the Centre for Addiction and Mental Health (CAMH) in collaboration with the Canadian Centre on Substance Use and Addiction (CCSA) and the Mental Health Commission of Canada (MHCC).
In the lead up to the conference, EENet is hosting a webinar series that aims to:
- Enhance knowledge of emerging evidence in the field of psychedelic substances for the treatment of mental health and substance use disorders
- Build relationships between stakeholders in the fields of psychedelics research, prescribing, and regulating, to assist in moving research into policy and practice
- Highlight the need for investment in psychedelics research
- Build interest in the 2022 From Research to Reality conference
The first webinar in this series was held on April 22, 2021 on “The intersection of science and spirit in psychedelics research.” The second webinar, titled “Ensuring safety for all in psychedelic medicine” was held on October 28, 2021.
Here are the conference recordings from Research to Reality on Vimeo.
Intended audience
The target audiences for this webinar series are researchers, clinicians, regulators and policy makers in the health sector, as well as individuals trained or in training as therapists for psychedelic-assisted clinical interventions. Members of the public are also welcome to attend. (Please note that the webinars will be in English only)
Project contact
For more information about the webinar series, contact emma.firsten-kaufman@camh.ca. For information about the global summit, see fromresearchtoreality.com.